Sarah Alam

Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials

Nicole Mayer-Hamblett, Félix Ratjen, Renee Russell et al. · The Lancet Respiratory Medicine · 2022 · 116 citations · Full text

Medicine, Hypertonic Saline, Dornase Alfa +1

High prevalence and a long delay in the diagnosis of primary aldosteronism among patients with young‐onset hypertension

Sarah Alam, Devasenathipathy Kandasamy, Alpesh Goyal et al. · Clinical Endocrinology · 2021 · 36 citations

The spectrum of manifestations of primary hyperparathyroidism in children and adolescents

Hiya Boro, Saurav Khatiwada, Sarah Alam et al. · Pediatric Endocrinology Diabetes and Metabolism · 2022 · 15 citations · Full text

46, XY complete gonadal dysgenesis with pubertal virilisation due to dysgerminoma/gonadoblastoma

Sarah Alam, Hiya Boro, Alpesh Goyal et al. · BMJ Case Reports · 2020 · 11 citations · Full text